Rachel Sorvig, a spokesperson for Zepbound and Mounjaro manufacturer Eli Lilly, said in a statement that users should "talk to their health care provider about dosage and duration needs." Studies have shown that people typically regain a substantial amount of weight within a year of stopping GLP-1 medications, and that many people who quit ultimately go back on the drugs
Patients taking semaglutide also showed markedly lesser declines of a key metric of kidney function called the estimated glomerular filtration rate, which was particularly pronounced among those with low baseline readings indicative of impairment, the researchers said, suggesting the drug may help protect people with pre-existing kidney impairments
Adding GIP appears to reinforce appetite control and metabolic flexibility
Healthcare professionals give enough guidance on the modification of sustainable lifestyle plan that matches the effects of semaglutide
However, the cortical volumetric bone mineral density (BMD)which reflects the density of BMC per unit areaappeared to have remained constant
Abstract Obesity is a multifaceted disease that significantly increases the risk of various chronic conditions
